News Aug 30, 2016 CardioCell announces positive results from phase IIa study evaluating IV administration of stem cells for chronic HF indications CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, announced data from its
Read More
CardioCell stem cells ‘improve well-being’ of heart failure patients
News Aug 29, 2016 CardioCell stem cells ‘improve well-being’ of heart failure patients After Celyad failed to reach its primary endpoints in a stem cell therapy test in heart patients back in June, CardioCell has felt the pressure to deliver--and over the weekend posted broadly
Read More
CardioCell offers bright spot in stem cell development
News Aug 29, 2016 CardioCell offers bright spot in stem cell development CardioCell reported positive Phase II data for its intravenous stem cell therapy for the treatment of chronic heart failure at the European Society of Cardiology meeting in Rome on Sunday. The study
Read MoreIV stem cell treatment safe, effective in patients with nonischemic HF
News Aug 29, 2016 IV stem cell treatment safe, effective in patients with nonischemic HF A single administration of IV allogeneic mesenchymal stem cells was safe and improved certain outcomes in patients with nonischemic HF with reduced ejection fraction, according to the results
Read MoreCardiocell’s stem cells via IV might be the answer in heart failure
News Aug 29, 2016 Cardiocell’s stem cells via IV might be the answer in heart failure Some chronic heart failure (HF) patients given an intravenous injection (IV) of specially prepared stem cells during a small phase IIa study saw significant functional and quality of life
Read MoreVIDEO: Dr. Javed Butler and Dr. C. Michael Gibson Discuss CardioCell Clinical Trial
News Aug 29, 2016 VIDEO: Dr. Javed Butler and Dr. C. Michael Gibson Discuss CardioCell Clinical Trial Dr. Javed Butler and Dr. C. Michael Gibson Discuss: Safety and efficacy of intravenous infusion of ischemia tolerant allogeneic mesenchymal stem cells in patients with non-ischemic
Read MoreStem cells to repair the heart. The enterprise is more difficult than expected
News Aug 28, 2016 Stem cells to repair the heart. The enterprise is more difficult than expected The idea is one that could revolutionize the treatment of heart disease: use stem cells to repair the heart in cases where it has been damaged by a heart attack or when it lost its
Read MoreStem-Cell Therapy Trials Miss Mark but Keep Hope Alive
News Aug 28, 2016 Stem-Cell Therapy Trials Miss Mark but Keep Hope Alive Two stem-cell trials, two negative primary end points, but signals of benefit in each may keep hope alive in patients with heart failure (HF), despite a decade of disappointment in the field. A phase 2a trial
Read More